MASHINIi

KORU Medical Systems, Inc..

KRMD.US | Manufacture of medical and dental instruments and supplies

KORU Medical Systems, Inc. is a medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients. The company's primary product is the FREEDOM System, a portable infusion s...Show More

Ethical Profile

Mixed.

KORU Medical Systems significantly impacts patient health, with its FREEDOM Infusion System serving over 45,000 patients and achieving a 97% adherence rate for PIDD therapy. The company holds over 70 global patents, reflecting its commitment to innovation in chronic illness solutions. However, a Sustainalytics ESG Risk Rating of 36.3 (High) indicates potential concerns. One adverse event was reported due to a defective device. Critics point to a lack of public data on crucial areas including product price accessibility, health equity programs, fair pay metrics, ethical sourcing practices, and environmental performance, making a comprehensive ethical assessment challenging. KORU does maintain a Code of Ethics and an Ethics Hotline, and no regulatory fines have been reported.

Value Scores

Better Health for All20
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-20
-100100
Kind to Animals40
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

20

KORU Medical Systems develops and manufactures subcutaneous infusion solutions for immunodeficiency patients, enabling home-based treatment and improving quality of life.

1
Their Freedom Infusion System is used by over 45,000 chronic, recurring SCIg patients globally, facilitating over 2 million annual infusions.
2
A 4.5-year study of 3,787 US PIDD patients using their systems demonstrated a 97% adherence rate to SCIg therapy.
3
The company reported one adverse event in May 2025 regarding a defective device that prevented a patient from administering a dose, causing a one-day delay.
4
KORU Medical has over 70 global patents and ongoing applications, and in 2024, it had 4 novel therapies collaborations, with 2 additional collaborations in early 2025.
5

Fair Money & Economic Opportunity

0

No evidence available to assess KORU Medical Systems, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

As of December 31, 2024, none of KORU Medical Systems' 80 full-time employees are represented by a collective bargaining agreement.

1
The company provides company-subsidized health insurance, a 401(k) Plan with company matching contributions, paid time off, and life and disability insurance.
2
The company's manufacturing operations depend on low-cost labor, and recent increases in minimum wage requirements in New York and New Jersey are expected to increase costs and reduce margins.
3
The company had 80 full-time employees as of December 31, 2024, a decrease from 82 employees as of December 31, 2023, representing a -2.44% employee growth rate.
4
The company acknowledges the need to attract and retain key employees.
5

Fair Trade & Ethical Sourcing

0

No specific, quantifiable evidence was found in the provided articles for any of the KPIs related to Fair Trade & Ethical Sourcing, such as fair-trade certification share, audit frequency, forced/child labor incidents, traceability coverage, remediation speed, ethical clause coverage in supplier contracts, share of spend on high-risk materials, or supplier diversity spend. While the company mentions FDA inspections of suppliers and risks related to single-source suppliers and manufacturing in Nicaragua, these do not provide the specific quantitative data required by the rubric's KPIs.

1

Honest & Fair Business

-20

KORU Medical Systems maintains an Ethics Hotline for employees, offering anonymous reporting, and states that all reports of inappropriate behavior are promptly investigated.

1
Its Anti-Corruption and Bribery Policy explicitly prohibits retaliation against individuals who raise concerns about bribery or corruption.
2
A class action complaint was filed against KORU Medical Systems for alleged violations of the Securities Exchange Act of 1934 between August 2020 and January 2021, alleging failure to disclose the use of allowances to incentivize growth.
3
The company has a clawback policy, effective June 2023, to recover incentive compensation in the event of an accounting restatement.
4
KORU Medical Systems selected Cherry Bekaert LLP as its independent registered public accounting firm for fiscal year 2025, with audit fees of $118,860 for 2024.
5
Five out of seven director nominees are independent, excluding the CEO and a former consultant.
6

Kind to Animals

40

KORU Medical Systems, Inc. has an absolute global ban on animal testing, as indicated by Sustainalytics data stating 'No' for animal testing.

1
This is further supported by CrueltyFreeInvesting.org listing the company as one that 'does not exploit animals'.
2
The company has used zero animals in any testing protocols, with this status confirmed by external sources.
3
Given the company's focus on medical infusion systems and the explicit 'No' for fur and specialty leather, it is assessed as having zero animal inputs in its product lines.
4

No War, No Weapons

0

No evidence available to assess KORU Medical Systems, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No evidence available to assess KORU Medical Systems, Inc. on Planet-Friendly Business.

Respect for Cultures & Communities

0

No evidence available to assess KORU Medical Systems, Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

No evidence available to assess KORU Medical Systems, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

The provided articles do not contain specific, quantitative data points for any of the KPIs related to Zero Waste & Sustainable Products. Information regarding waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero waste certifications, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education is not available in the provided documents.

1

Own KORU Medical Systems, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.